Global Research Antibodies Outlook to 2028: Rise in R&D Initiatives and an Increase in Neurobiology and Stem Cell Research are Key Factors in Market…

Dublin, Dec. 03, 2021 (GLOBE NEWSWIRE) -- The "Global Research Antibodies Market Size, Share & Trends Analysis Report by Product (Primary, Secondary), by Type (Monoclonal Antibodies, Polyclonal Antibodies), by Technology, by Source, by Application, by End-use, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global research antibodies market size is expected to reach USD 5.9 billion by 2028. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028.

Major market drivers include a rise in R&D initiatives undertaken by biopharmaceutical and biotechnology companies and government bodies, an increase in neurobiology and stem cell research, availability of technologically advanced products, and strategic collaborations among various key players.

An increase in the usage of research antibodies to develop therapies for various chronic and infectious diseases, including COVID-19, is anticipated to boost the market growth during the forecast period. For instance, in June 2019, the Institute of Life Sciences (ILS, India) developed antibodies against chikungunya viral infection.

These antibody structures were developed to aid scientists in understanding various aspects of virus pathogenesis entailing further research on antiviral therapies. Growing government funds and initiatives for R&D are anticipated to fuel market growth during the forecast period in the Asia Pacific region.

According to the 2018-2019 Australian Budget, approximately USD 94 million was estimated for four years for new industry collaborations, research as well as new biomedical and medical programs.

Additionally, a rise in funds invested by pharmaceutical and biotechnology companies to enhance proteomics and genomics research is expected to boost market growth. For instance, in 2017, Biognosys Inc. raised USD 5 million in funds to increase, advance, and develop next-generation proteomics products and workflow for high throughput and high content protein analysis.

The rise in the number of major players investing in advanced technologies and collaborating with other key players is also anticipated to impact market potential positively in the near future. For instance, Abcellera uses technologically advanced techniques to test antibodies from single B cells, map and screen natural immune responses, and discover novel antibody therapies.

The company has also partnered with Sanofi, Pfizer, Teva, Merck, and GSK to discover and develop new antibody-based therapies. Moreover, the launch of novel antibody structures for the diagnosis of various diseases is also a major factor expected to boost market growth. For instance, in August 2018, BioGenex launched a range of new antibodies for its use in cancer immunohistochemistry.

Research Antibodies Market Report Highlights

Key Topics Covered:

Research Antibodies Market Variables, Trends & Scope

Research Antibodies Market - Competitive Analysis

Research Antibodies Market: Product Estimates And Trend Analysis

Research Antibodies Market: Type Estimates And Trend Analysis

Research Antibodies Market: Technology Estimates And Trend Analysis

Research Antibodies Market: Application Estimates And Trend Analysis

Research Antibodies Market: Source Estimates And Trend Analysis

Research Antibodies Market: End-use Estimates And Trend Analysis

Research Antibodies Market: Regional Estimates & Trend Analysis

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/cifvgm

Read this article:

Global Research Antibodies Outlook to 2028: Rise in R&D Initiatives and an Increase in Neurobiology and Stem Cell Research are Key Factors in Market...